SCHEMBL7948347

SCHEMBL7948347

Bc1ccc2c(c1)C(=O)CC(c1cccs1)O2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 8/20 0.45
SLC22A12 Q96S37 5/20 0.43
CYP3A4 P08684 1/20 0.42
ABCB1 P08183 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ADORA3 P0DMS8 2/20 0.41
MAOB P27338 2/20 0.41
CYP19A1 P11511 1/20 0.41
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
STS P08842 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
6-Bromo-2-(Thiophen-2-Yl)Chroman-4-One SCHEMBL1824814 0.84 AR (0.58) ARSLC22A12CYP3A4ABCB1ABCG2
SCHEMBL7958829 0.79 AR (0.69) ARCYP3A4ABCB1ABCG2KDM4E
SCHEMBL7954899 0.74 RAB9A (0.58) ARABCB1ABCG2KDM4EHSD17B10
SCHEMBL7956418 0.74 KDM4E (0.68) ARCYP3A4ABCB1ABCG2KDM4E
SCHEMBL7958698 0.74 AR (0.52) ARCYP3A4ABCB1ABCG2KDM4E
SCHEMBL7967068 0.73 MAOB (0.66) ARABCB1ABCG2KDM4EHSD17B10
SCHEMBL7958385 0.73 AR (0.50) ARCYP3A4ABCB1ABCG2KDM4E
SCHEMBL7959576 0.73 AR (0.47) ARCYP3A4ABCB1ABCG2KDM4E
SCHEMBL7964702 0.72 KDM4E (0.56) ARCYP3A4ABCB1ABCG2KDM4E
SCHEMBL7957819 0.71 ABCB1 (0.67) ARCYP3A4ABCB1ABCG2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010021680-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-02-25 WO disclosed